Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M5CD
|
|||
| Former ID |
DNCL002733
|
|||
| Drug Name |
Doxorubicin-eluting beads
|
|||
| Synonyms |
DC Bead (TN)
Click to Show/Hide
|
|||
| Indication | Liver cancer [ICD-11: 2C12; ICD-10: C22] | Phase 2 | [1] | |
| Company |
Bayer HealthCare Pharmaceuticals; Biocompatibles
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | DNA topoisomerase II (TOP2) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026037) | |||
| REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.